INCLIVA - Banco de Patentes
PRECISION MEDICINE UNIT
"Vanguard technology at the service of the research" Our mission is to impulse, promote and execute a quality translational research offering support in molecular biology as in computing...
DRUG REPURPOSING FOR ATHEROSCLEROSIS TREATMENT
New medical use of P15/P16 agonists for the treatment of atherosclerosis. These drugs would act as stabilizers of atheroma plaque through a new mechanism of action based on immune system...
PPAR-alpha/gamma AGONISTS
Researchers from INCLIVA has synthesised a novel family of drug candidates with dual PPAR-alpha/ activity. This compounds are characterized by their improvement of lipid and glycaemic parameters...
ANTISENSE RNA-THERAPEUTICS IN MYOTONIC DYSTROPHY
Myotonic Dystrophy (DM, overall prevalence of 1/8000) is a highly disabling multisystemic disease with symptoms involving the nervous system, the heart, and the skeletal musculature. In its most...
Translational research in solid tumours
The Research Group on Translational Research in solid tumours aims to develop new therapeutic interventions to improve the diagnosis and prognosis of patients suffering from cancer related to the...
Phase I Oncological Clinical Trials Unit
The at the Hospital Clínico Universitario in Valencia —where the efficacy of a drug for treating cancer is tested for the first time in humans— was created in 2004 and is pioneering in Spain....
Big data for health
INCLIVA research line in Big Data aims at breaking down barriers of conventional health system thorough collaborative innovation and smart use of clinical data. Our research is also aimed at...
Method for predicting the prognosis and probable evolution of patients with sepsis, severe sepsis, and septic shock
Researchers of INCLIVA Biomedical Research Institute, University of Valencia and CIBER have developed a fast biomarker-based method to accurately diagnose and prognose severe sepsis and septic...
New tools for diagnosis, prediction and prevention of myocardial ifarction
Researchers of INCLIVA Biomedical Research Institute and University of Valencia have developed new tools to predict and diagnose myocardial infarction. These tools are based on image analysis and...
Angiopath: A tool to quantify and morphologically characterize blood and lymph vessels
Researchers of INCLIVA Biomedical Research Institute, University of Valencia, University of Castilla La Mancha and Andalucia Public Health System have developed ANGIOPATH, a morphometric tool able...
Compound for preventative treatment of Alzheimer disease
Researchers of INCLIVA Biomedical Research Institute and University of Valencia have shown the effectiveness of a compound in the treatment of the Alzheimer disease and mild cognitive impairment...
Prótesis personalizadas para los huesos de la cara u mandíbula
Prótesis maxilo-mandibular altamente resistente que se adapta perfectamente a la anatomía del paciente gracias a su diseño a medida, a partir de un modelo 3D obtenido de imágenes del paciente, y a...
Design and manufacturing of genetic diagnosis kits.
INCLIVA offers the know-how and experience of its Genotyping and Genetic Diagnosis Unit to those interested in designing or manufacturing in vitro diagnosis kits base on genetic, epigenetic or...
Detection of impaired brain through magnetic resonance imaging
Neuroimagen technics based on magnetic resonance are not sensible enough to detect small anatomic alterations in the brain. The proposed technology solves this limitation, improving greatly the...